SHARES in FTSE 100 drugmaker Shire soared 430p to 3500p after it emerged as a £35billion takeover target for Japan’s biggest pharma company. Takeda Pharmaceutical is considering an approach to Shire as it looks to strengthen its core therapeutic areas of oncology and neuroscience.
Source: Daily Express :: Finance Feed https://ift.tt/2pP2Evr
EmoticonEmoticon